Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-115794

Chief Executive Officer sold 1,300 shares at an average $20.12 ($26,159)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-04-25 Sale : show line 1 in the form −1,200 $20.12 $24,144 363,611 I
2016-04-26 Sale : show line 2 in the form −100 $20.15 $2,015 363,511 I
Open-market sales · 1,300 sh · avg $20.12 · $26,159
Loading xslF345X03/doc4.xml…